News
Uncoordinated price cuts across the EU are contributing to medicine shortages and driving manufacturers towards more ...
The amended product information will provide more specific detail on encephalitis as a known adverse reaction to ...
The European Union’s health regulator has lifted the temporary restriction on the use of French drugmaker Valneva’s ...
In discussions with multiple potential animal health company partners to collaborate to bring Canalevia®, conditionally ...
People of a certain age may remember Merthiolate and Mercurochrome in the household medicine chest. Whenever someone skinned ...
FDA reviewers have identified high rates of ocular toxicity as GSK looks to place its blood cancer drug back on the market.
Novo Nordisk A/S (NYSE:NVO) is one of the 10 Best Growth Stocks to Buy With Huge Upside Potential. On June 23, Novo Nordisk A ...
Denmark's Novo Nordisk said on Tuesday it had submitted a new, higher dose of its obesity treatment Wegovy to the European Medicines Agency for approval, with one in three trial participants achieving ...
New Drug Submission meeting scheduled with Health Canada for the third quarter of 2025Initial briefing book submitted for review to the European Medicines Agency WARREN, N.J., July 15, 2025 (GLOBE ...
JHU's Neurofibromatosis Therapeutic Acceleration Program celebrated the 10th anniversary of its Francis S. Collins Scholars ...
July, 11 2025 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) will lift the temporary restriction on vaccinating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results